Sonnet BioTherapeutics Holdings, Inc. (SONN): Price and Financial Metrics
SONN Price/Volume Stats
| Current price | $1.54 | 52-week high | $18.72 |
| Prev. close | $1.54 | 52-week low | $1.41 |
| Day low | $1.50 | Volume | 67,000 |
| Day high | $1.57 | Avg. volume | 311,564 |
| 50-day MA | $2.22 | Dividend yield | N/A |
| 200-day MA | $7.41 | Market Cap | 4.63M |
SONN Stock Price Chart Interactive Chart >
Sonnet BioTherapeutics Holdings, Inc. (SONN) Company Bio
Sonnet BioTherapeutics Holdings, Inc. operates as a clinical stage biotechnology company. The Company develops fully human albumin binding technology that helps the development of innovative targeted biologic drugs with enhanced single-or bi-specific mechanisms. Sonnet BioTherapeutics Holdings serves customers in the United States.
SONN Price Returns
| 1-mo | -1.28% |
| 3-mo | -74.92% |
| 6-mo | -77.36% |
| 1-year | -85.42% |
| 3-year | -99.81% |
| 5-year | -100.00% |
| YTD | 5.48% |
| 2024 | -89.51% |
| 2023 | -93.12% |
| 2022 | -80.12% |
| 2021 | -81.48% |
| 2020 | -85.46% |
Loading social stream, please wait...